Rallybio Corp [NASDAQ: RLYB] surged by $0.17 during the normal trading session on Tuesday and reaching a high of $0.6048 during the day while it closed the day at $0.51.
Rallybio Corp stock has also gained 51.30% of its value over the past 7 days. However, RLYB stock has inclined by 13.64% in the 3 months of the year. Over the past six months meanwhile, it has lost -46.18% and lost -60.05% year-on date.
The market cap for RLYB stock reached $21.29 million, with 41.61 million shares outstanding and 19.88 million shares in the current float. Compared to the average trading volume of 200.92K shares, RLYB reached a trading volume of 151303466 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Rallybio Corp [RLYB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RLYB shares is $1.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RLYB stock is a recommendation set at 2.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Rallybio Corp shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on April 09, 2025. The new note on the price target was released on May 15, 2024, representing the official price target for Rallybio Corp stock. Previously, the target price had yet another drop from $7 to $1.50, while Jefferies kept a Hold rating on RLYB stock.
The Price to Book ratio for the last quarter was 0.39, with the Price to Cash per share for the same quarter was set at 1.31.
RLYB stock trade performance evaluation
Rallybio Corp [RLYB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 51.30. With this latest performance, RLYB shares gained by 50.77% in over the last four-week period, additionally sinking by -46.18% over the last 6 months – not to mention a drop of -46.73% in the past year of trading.
Rallybio Corp [RLYB]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Rallybio Corp [RLYB] shares currently have an operating margin of -5940.92% and a Gross Margin at 85.38%. Rallybio Corp’s Net Margin is presently recorded at -5682.19%.
Return on Equity for this stock declined to -61.25%, with Return on Assets sitting at -61.25%.
Rallybio Corp [RLYB]: Institutional Ownership
There are presently around $76.90%, or 80.24% of RLYB stock, in the hands of institutional investors. The top three institutional holders of RLYB stocks are: VIKING GLOBAL INVESTORS LP with ownership of 4.19 million shares, which is approximately 10.288%. JOHNSON & JOHNSON, holding 3.64 million shares of the stock with an approximate value of $$4.87 million in RLYB stocks shares; and JOHNSON & JOHNSON, currently with $$4.87 million in RLYB stock with ownership which is approximately 8.9046%.
